Literature DB >> 22425228

The human IL-7 receptor gene: deletions, polymorphisms and mutations.

Renata I Mazzucchelli1, Agostino Riva, Scott K Durum.   

Abstract

Most T cell subsets depend on IL-7 for survival. IL-7 binds to IL-7Rα and γc, initiating the signaling cascade. Deletion of IL-7Ra in humans has, for some time, been known to cause severe combined immunodeficiency. More recently, polymorphisms in IL-7R have been shown be a risk factor for a number of diseases that are autoimmune or involve excess immune and inflammatory responses including multiple sclerosis, type 1 diabetes, rheumatoid arthritis, primary biliary cirrhosis, inflammatory bowel disease, atopic dermatitis, inhalation allergy, sarcoidosis and graft-versus host disease. The polymorphism that affects risk to most of these immunopathologies is T244I at the border of the extracellular domain and the transmembrane region. The same region has recently been shown to harbor gain-of-function mutations in acute lymphoblastic leukemia. These studies have suggested new therapies that target the IL-7 pathway. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22425228      PMCID: PMC6326362          DOI: 10.1016/j.smim.2012.02.007

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  23 in total

Review 1.  IL7RA genetic variants differentially affect IL-7Rα expression and alternative splicing: a role in autoimmune and infectious diseases?

Authors:  Christian Lundtoft; Julia Seyfarth; Marc Jacobsen
Journal:  Genes Immun       Date:  2020-01-13       Impact factor: 2.676

2.  Association between the IL7R T244I polymorphism and multiple sclerosis risk: a meta analysis.

Authors:  Song Wu; Qian Liu; Ji-Min Zhu; Ming-Rui Wang; Jing Li; Mei-Guo Sun
Journal:  Neurol Sci       Date:  2016-05-17       Impact factor: 3.307

3.  Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity.

Authors:  Alice Melão; Maureen Spit; Bruno A Cardoso; João T Barata
Journal:  Haematologica       Date:  2016-07-28       Impact factor: 9.941

4.  Interleukin-7 in the transition of bone marrow progenitors to the thymus.

Authors:  Adam W Plumb; Abdalla Sheikh; Douglas A Carlow; Daniel T Patton; Hermann J Ziltener; Ninan Abraham
Journal:  Immunol Cell Biol       Date:  2017-08-16       Impact factor: 5.126

Review 5.  Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia.

Authors:  Noa Tal; Chen Shochat; Ifat Geron; Dani Bercovich; Shai Izraeli
Journal:  Cell Mol Life Sci       Date:  2013-04-27       Impact factor: 9.261

6.  IL-7/anti-IL-7 mAb complexes augment cytokine potency in mice through association with IgG-Fc and by competition with IL-7R.

Authors:  Christopher E Martin; Ester M M van Leeuwen; Se Jin Im; Derry C Roopenian; Young-Chul Sung; Charles D Surh
Journal:  Blood       Date:  2013-04-22       Impact factor: 22.113

Review 7.  Structural insights into the common γ-chain family of cytokines and receptors from the interleukin-7 pathway.

Authors:  Scott T R Walsh
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

Review 8.  Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment.

Authors:  Sarah D Cramer; Peter D Aplan; Scott K Durum
Journal:  Blood       Date:  2016-06-06       Impact factor: 22.113

9.  Cytokine profiling of young overweight and obese female African American adults with prediabetes.

Authors:  Rudolf Lucas; Samip J Parikh; Supriya Sridhar; De-Huang Guo; Jigar Bhagatwala; Yutong Dong; Ruth Caldwell; Andrew Mellor; William Caldwell; Haidong Zhu; Yanbin Dong
Journal:  Cytokine       Date:  2013-06-12       Impact factor: 3.861

10.  Interleukin (IL)-7 Signaling in the Tumor Microenvironment.

Authors:  Iwona Bednarz-Misa; Mariusz A Bromke; Małgorzata Krzystek-Korpacka
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.